A Case Report of the Management of Residual Cardiovascular Risk in a Dyslipidaemic Patient with Metabolic Syndrome

Abstract

Metabolic Syndrome (MS) is a clustering of metabolic and underlying risk factors
which doubles the risk of atherosclerotic cardiovascular disease. It is more prevalent in some
ethnic groups, especially in the Asian world. Global urbanization and sedentary life habits
have increased the underlying risk factors characterised by physical inactivity, atherogenic diet
and obesity. Therefore, its detection, prevention, and treatment serve as an important approach
for the reduction of cardiovascular risk in the general population and strictly emphasized on
strict therapeutic lifestyle changes. In our case report, we present effective management of a
dyslipidaemic patient with MS by medication. However, her underlying risk factors were not
controlled due to her inability to strictly adopt therapeutic lifestyle changes.